|
| |
BioEmail targeted email Immunology List
Immunology email list.
This is a broad list encompassing many individuals from those who would
consider themselves “immunologists” to those working in related fields such
as virology and infectious diseases. Primarily basic scientists; the list
includes clinicians, commercial scientists and academics.
Current number on list : 58,102*
Regional Breakdown Percentage
-
Europe 33.2%
-
USA 29.3%
-
Rest of World 37.5%
Keywords:
• Immunology
• Immune
• Cytokine
• Vaccine
• Interleukin
• T-cell
Typically a list is focused more specifically on a client’s target area, for
example by utilising additional restrictive keywords in addition to the
above.
Top Countries
-
USA 29.3%
-
Japan 8.3%
-
Germany 5.7%
-
UK 4.9%
-
Italy 3.7%
-
France 3.6%
-
Canada 2.5%
-
Netherlands 2.1%
Sector Distribution
-
Academic (.ac., .edu etc.) 55.2%
-
Commercial (.com, .co.uk etc.) 5.1%
-
Government (.gov etc.) 1.4%
-
Other (Mainly country TLDs eg. .de, .jp
etc.) 38.4%
Example Job Titles:
• Professor
• Researcher
• Scientist
• Immunologist
• Group leader
• Principle Investigator
Sample Grantholders
xxx@mail.med.upenn.edu
The Human Platelet in Immunohematologic Disease
xxx@tufts.edu
IMMUNOREGULATION IN SCHISTOSOMIASIS
xxx@vet.upenn.edu
Developmental Control of Immunoglobulin Transcription
xxx@usuhs.mil
Immunomodulation by Pregnancy Specific Glycoprotein 17
xxx@immunology.wustl.edu
T Cell Recognition of Antigen
xxx@medctr.osu.edu
THE IMMUNOBIOLOGY OF MURINE ALLOGRAFT ACCEPTANCE
xxx@uchicago.edu
Immunoglobulin Somatic Mutation
xxx@mail.med.upenn.edu
Placental Protein 14 as a Lectin-Like Immunomodulator
xxx@fhcrc.org
Structure/function studies of CTLD NK immunoreceptors
xxx@u.washington.edu
MECHANISMS OF SOMATIC MUTATION OF IMMUNOGLOBULIN GENES
Sample Published Authors
xxx@unimelb.edu.au
Vaccines against cysticercosis and hydatidosis: foundations in taeniid
cestode immunology.
xxx@imperial.ac.uk
Quantification of the virus-host interaction in human T lymphotropic virus I
infection.
xxx@uni-tuebingen.de
Immunosenescence, suppression and tumour progression.
xxx@charite.de
[Modern immunosuppression following renal transplantation. Standard or
tailor made?]
xxx@mail.nih.gov
Serum lipid levels in SjÃgren's syndrome.
xxx@mahidol.ac.th
Incidence and clinical correlation of anticentromere antibody in Thai
patients.
xxx@ncbi.nlm.nih.gov
The cytidine deaminase AID exhibits similar functional properties in yeast
and mammals.
xxx@uq.edu.au
Engineering of needle-free physical methods to target epidermal cells for
DNA vaccination.
xxx@mssm.edu
Advances in the Pathogenesis of Inflammatory Bowel Disease.
xxx@informa.com
Cell adhesion molecules as therapeutic targets: interview with Professor
Michael P SchÃn.
xxx@gxmu.net.cn
[Research Progression on Complement Regulatory Proteins CD46, CD55,and CD59
in Tumor Immunotherapy.]
Example companies
• Serono
• Biogen
• Aventis
• Astrazeneca
• Biogen
• Roche
• Celera
• Epiva
• Allergan
• Genzyme
Call us to discuss your specific requirements:
Peter Barfoot . Tel: (+44) 1300 321501
From USA: 011 44 1300 321 501
Peter.Barfoot@bioportfolio.com
http://www.bioportfolio.com/advertis/bioemail.htm
* Our database is constantly being updated and edited. Newly published
authors and grant applicants are added daily and emails which become disused
are constantly purged from our system.
| |
|